Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
06/2004
06/02/2004EP1423429A2 Antibodies against caspase-8, their preparation and use
06/02/2004EP1423425A2 Receptor, the use thereof, and mouse antibodies
06/02/2004EP1423415A2 Intracellular signaling molecules
06/02/2004EP1423413A1 Peptidic compounds selectively binding to p-selectin
06/02/2004EP1423412A2 Homing peptides
06/02/2004EP1423136A1 Polypeptide conjugates with extended circulating half-lives
06/02/2004EP1423135A2 Methods for inhibiting angiogenesis
06/02/2004EP1214589B1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures
06/02/2004EP0948344A4 Synthetic antibiotics
06/02/2004CN1500873A Nereides protease, separating and purifying method and application thereof
06/02/2004CN1152052C Process for preparing thymus peptide
06/02/2004CN1152049C Treatment of insulin resistance with growth hormone secretagogues
06/02/2004CN1152047C Process for extracting thallus from waste liquid of monosodium glutamate
06/02/2004CN1151839C In-colon release-controlled thymopeptide capsule and process for extracting and separating thymopeptide
06/01/2004USRE38524 Dipeptide derivatives as growth hormone secretagogues
06/01/2004US6743945 Carboxylic acid and amino acid or amino condensate reactants and manufacturing method therefor
06/01/2004US6743899 Process for inactivating prions in lipoproteins
06/01/2004US6743892 Molecules that home to a selected organ in vivo
06/01/2004US6743771 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating alzheimer's disease or creutzfelds-jakob disease for example
06/01/2004US6743630 Method of preparing a protein array based on biochemical protein-protein interaction
06/01/2004CA2174231C Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained
05/2004
05/27/2004WO2004044011A2 Combinatorial libraries of monomer domains
05/27/2004WO2004043995A2 Process for the preparation of glatiramer acetate by polymerisation of n-carboxy anhydrides of l-alanine, l-tyrosine, benzyl l-glutamate and benzyloxycarbonyl l-lysine
05/27/2004WO2004043386A2 Molecules preferentially associated with effector t cells and methods of their use
05/27/2004WO2004043238A2 Biomarkers for intra-amniotic inflammation
05/27/2004WO2004043141A2 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
05/27/2004WO2004026893A3 Synthetic chemokines labeled at selected positions
05/27/2004WO2004014941A8 Method for selective peptide labeling
05/27/2004WO2002081413A3 One dimensional unichemo protection (ucp) in organic synthesis
05/27/2004US20040102936 Method and system for designing and evaluating linear polymers
05/27/2004US20040102804 Apparatus and methods for endoscopic surgical procedures
05/27/2004US20040102615 Method for isolating and purifying a protein and resulting protein
05/27/2004US20040101963 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
05/27/2004US20040101947 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell
05/27/2004US20040101939 Using maleuric acidic addition to decrease changes to immunoglobulins produced in milk of trangenic goats
05/27/2004US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer
05/27/2004US20040100268 Method and apparatus for separating biological molecules
05/27/2004DE10253483A1 Assembly for membrane electrophoresis of dissolved/dispersed substances using micro filtration membranes, maintains a pressure difference at the membranes to reduce electro osmotic flows
05/27/2004CA2505546A1 Molecules preferentially associated with effector t cells and methods of their use
05/27/2004CA2504670A1 Combinatorial libraries of monomer domains
05/26/2004EP1421539A2 Stabilized proteins with engineered disulfide bonds
05/26/2004EP1421373A2 Apparatus and method for separating an analyte
05/26/2004EP1421103A2 Method for making acylated polypeptides
05/26/2004EP1421102A2 Method for making acylated polypeptides
05/26/2004EP1420681A2 Peptide-based multimeric targeted contrast agents
05/26/2004EP1420646A1 Antimicrobial agent
05/26/2004EP1159296B1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly)
05/26/2004CN1498899A Vegetable protein as well as preparation method and application
05/26/2004CN1151374C Self-addressable self-assembling microelectronic system and devices for molecular biological analysis and diagnostics
05/26/2004CN1151258C Prodn. of erythropoietin by endogenous gene activation
05/26/2004CN1151254C Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases
05/26/2004CN1151172C Novel membrane proteine P76 of helicobacter pylori
05/25/2004US6740506 End selection in directed evolution
05/25/2004US6740502 Chelation in presence of protease; bioavailability
05/25/2004CA2260795C Synthetic protein folding catalysis
05/21/2004WO2004042350A2 Using amines or amino acids as mobile phase modifiers in chromatography
05/21/2004WO2004042019A2 Systems for capture and analysis of biological particles and methods using the systems
05/21/2004WO2004042012A2 Process for concentration of macromolecules
05/21/2004WO2004042003A2 Cell lysis compositions, methods of use, apparatus, and kit
05/21/2004WO2004041848A1 Improved extraction of a proteinaceous macromolecule from a biological sample
05/21/2004WO2004041840A2 Peptide-bound chromogens used for determining enzymatic activities
05/21/2004WO2004041182A2 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
05/21/2004WO2004000032A3 Colour reduction in canola protein isolate
05/21/2004WO2003102190A3 Bacterial polypeptides involved in viability
05/21/2004WO2002081490A8 Computer-directed assembly of a polynucleotide encoding a target polypeptide
05/21/2004WO2002074791A8 Method for purification of molecules using unbranched terminal alkyldiols
05/21/2004CA2504481A1 Systems for capture and analysis of biological particles and methods using the systems
05/21/2004CA2504129A1 Cell lysis compositions, methods of use, apparatus, and kit
05/20/2004US20040098755 Comprises nucleotide sequences coding embryonic glycoprotein for use in the treatment and prevention of autoimmune, cell proliferative and immunological disorders; immunosuppressants; antiproliferative agents
05/20/2004US20040097715 Recovering polypeptides which have leached from cells made porous via electric pulse
05/20/2004US20040097413 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
05/20/2004US20040096889 Compositions, organisms and methodologies employing a novel human kinase
05/20/2004US20040096878 For anticancer/tumor agents; in vivo gene expression profiling; solid phase synthesis
05/20/2004US20040096394 Conjugating radioiodinated peptides to non-metabolizable carbohydrates
05/19/2004EP1419428A2 Ensemble-based strategy for the design of protein pharmaceuticals
05/19/2004EP1419393A1 Tumor specific oligosaccharide sequences and use thereof
05/19/2004EP1419249A2 TIMM8b-RELATED PROTEIN
05/19/2004EP1419177A2 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine
05/19/2004EP1419172A2 Bi-directional synthesis of oligoguanidine transport agents
05/19/2004EP1419171A1 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution
05/19/2004EP1418933A2 Process for preparing glycopeptide phosphonate derivatives
05/19/2004EP0954528B1 A method for chromatographic removal of prions
05/19/2004EP0888157B1 Process for chromatographic separation of peptides and nucleic acid, and new high affinity ion exchange matrix
05/19/2004DE10251894A1 New peptide-containing benzophenoxazine or napthoquinone derivatives, useful as chromogenic substrates for enzymes, e.g. for diagnosis, monitoring therapy and detecting pyrogens
05/19/2004CN1498225A Template-fixed peptidomimetics with antimicrobial activity
05/19/2004CN1498103A Novel use of peptide class of compound for treating non-neuropathic inflammatory pain
05/19/2004CN1497047A Expression system for producing recombination tryptophanase and preparation method and application of recombination tryptophanase
05/19/2004CN1150403C Compbinatorial libraries having predetermined frequency of each species of test compound
05/19/2004CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies
05/18/2004US6737409 For cancer therapy
05/18/2004US6737403 Culturing microorganism streptomyces viridochromogenes, ssp. komabensis (atcc 29814) in culture medium, isolating laspartomycin, cleaving lipophilic fragment from laspartomycin, thereby yielding laspartomycin core peptide
05/18/2004US6737241 Methods for screening for transdominant intracellular effector peptides and RNA molecules
05/18/2004US6737236 Derivatizing oligonucleotides and proteins using cycloaddition reactions including diels-alder reaction or 1,3-dipolar cycloaddition reactions
05/18/2004CA2042945C Protein purification method
05/13/2004WO2004040315A1 Process for producing labeled nucleic acid or protein
05/13/2004WO2004039962A2 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
05/13/2004WO2004039382A1 Enhanced production of clotting factors by cryoprecipitation
05/13/2004WO2004029077A3 Method for producing acylated peptides
05/13/2004WO2003054524A9 Microfluidic devices and methods for two-dimensional separations
05/13/2004WO2003052050A3 P450 enzymes, nucleic acids encoding them and methods of making and using them